Studienlage zu Artemisia annua und Krebs



  • Studie zu Brustkrebszellen:
    Study of Artesunate in Metastatic Breast Cancer. Efferth et al., Inter. J. Oncology 18: 767, 2001 (auch unter http://clinicaltrials.gov/show/NCT00764036)

  • Studie zu Gebärmutterhalskrebs:
    First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers. Frans Herwig Jansen, Innocent Adoubi, Kouassi Comoe J.C., Tinne De Cnodder, Nicolas Jansen, Alexander Tschukalow and Thomas Efferth, Anticancer Research 31:4417-4422 (2011)

  • Studie zur Apoptose (Selbstmord) der Krebszelle:
    Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalysed lysomalreactive oxygen species production. Hamacher-Brady, A. u.a., J. Biol Chem, 25.2.2011; 286 (8): 6587-6601, DOI: 10.1074/jbc.M110.210047

  • Studie zu Darmkrebs:
    EBioMedicine. A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer. Sanjeev Krishna, Senthil Ganapathi, Irina Chis Ster, Mohamed E.M. Saeed, Matt Cowan, Caroline Finlayson, Hajnalka Kovacsevics, Herwig Jansen, Peter G. Kremsner, Thomas Efferth, Devinder Kumar. 2014
       
  • Allgemein:
    From ancient herb to versatile, modern drug: Artemisia annua and artemisinin for cancer therapy. Thomas Efferth, Johannes Gutenberg University, Institute of Pharmacy and Biochemistry, Department of Pharmaceutical Biology, Mainz, Elsevier 2017